MD Biosciences Blog

MCRH Wins Contract for Phase I Clinical Trial

MD Biosciences Announces Launch of Salspera, LLC To Advance Saltikva® (MDB401B) Towards Regulatory Approval As Cancer Immunotherapeutic

NEW CLINICAL RESEARCH CONSORTIUM PROVIDES INTEGRATED DEVELOPMENT PLATFORM IN MEDICAL ALLEY

MD Biosciences to present new advances in pig translational models for pain

MD Biosciences Expands Histology and IHC Capabilities

MD Biosciences Announces Facility Expansions

MD Biosciences Announces License to Colorectal Cancer Markers

MD Biosciences to Present At 13th Int'l Neuroimmunology Congress

Preclinical Study | Microbiome Effects | Metastatic Tumor Progression

Accelerating Academic Life Science Technology Discoveries

Zika Virus Test Update

MD Biosciences Announces Release of Zika Virus Diagnostic Test

MD Biosciences Announces Addition of Cancer Suite

MD Biosciences Releases NeuroFreeze | Preserve Primary Neurons

MD Biosciences & Janssen R & D, LLC to screen extensive library of compounds.

MD Biosciences Receives AAALAC Accreditation

MD Biosciences Screens Large Pharma Co. Compounds w/its Senerga® Platform

MD Biosciences Syngeneic Tumor Models for Primary Orthotopic & Metastasis.

MD Biosciences POP Pain Model Published in European J Pain

IL-23 induced Psoriasis-like Preclinical Model of Inflammation

Expansion of the US Preclinical Contract Research Lab

MD Biosciences Releases Sciatic Nerve Block Model

MD Biosciences Develops Large Animal Neuropathic Pain Model

3D Human Skin System w/Co-Cultures & Vasclr tech. Closely Resembles Human Skin

Preclinical Imiquimod-induced Psoriasis-like Skin Inflammation Model

Preclinical Efficacy Models of Parkinson's Disease: 6OHDA & Acute MPTP

eBook: Pain & Inflammation Link | Targets in the Overlap

High ArthritoMabTM Antibody Cocktail Activity | 18-day RA Model Balb/c Mice

Occlusion-induced Myocardial Infarct Model Studies Cardio Protection

MD Biosciences Launches New Products Division - MD Bioproducts

MD Biosciences Expands Pre-clinical Inflammatory & Neuro Drug Research

MD Biosciences Releases Tamm-Horsfall (Uromodulin) ELISA

PharmaGap & MD Biosciences Pursue Novel Inflammatory & Neuro PKC Theta Inhibitor

MD Biosciences Adds Myocardial Infarct Models to its Porfolio

MD Biosciences Releases Human Collagen Type I ELISA

Lumican & Keratocan Monoclonal Antibodies | Eye/Cornea

MD Biosciences to Showcase Preclinical Capabilities at Neuroscience Conf

MD Biosciences Showcases its Products & Services at APLAR Conference.

MD Biosciences Showcases Preclinical Disease Models at Int’l IRA Conference

MD Biosciences Offers Monoarthritic Pain Model

MD Biosciences to Showcase Preclinical Capabilities at World Pain Congress

New Mouse anti-Collagen Type II (anti-CII) ELISAs.

MD Biosciences Releases Mouse OVA-IgE ELISA

High ArthritoMabTM Antibody Cocktail Activity |18-day RA Model Balb/c Mice

MD Biosciences Releases New - Improved Collagen Type II ELISA